Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Futures Kickoff
Get prepared for your futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to experience risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Xinhua Pharmaceutical (000756) on March 6th, main funds net bought 2.7296 million yuan
Securities Star News: As of the close on March 6, 2026, XinHua Pharmaceutical (000756) closed at 15.38 yuan, up 1.52%, with a turnover rate of 1.16%, a trading volume of 57,700 lots, and a transaction amount of 88.276 million yuan.
Regarding capital flow data on March 6, main funds had a net inflow of 2.7296 million yuan, accounting for 3.09% of the total transaction amount; hot money had a net outflow of 2.1399 million yuan, accounting for 2.42%; retail investors had a net outflow of 589,600 yuan, accounting for 0.67%.
XinHua Pharmaceutical’s 2025 third-quarter report shows that the company’s main business revenue for the first three quarters was 6.763 billion yuan, a year-on-year increase of 0.42%; net profit attributable to the parent was 256 million yuan, a decrease of 25.53% year-on-year; non-recurring net profit was 239 million yuan, down 25.62% year-on-year. In the third quarter of 2025, the company’s single-quarter main business revenue was 2.124 billion yuan, up 6.1% year-on-year; net profit attributable to the parent was 32.464 million yuan, down 58.74%; non-recurring net profit was 28.196 million yuan, down 60.86%. The debt ratio is 40.72%, investment income is 6.1027 million yuan, financial expenses are 20.9693 million yuan, and gross profit margin is 19.17%. XinHua Pharmaceutical (000756) mainly develops, manufactures, and sells chemical raw materials, formulations, pharmaceutical intermediates, and other products.
Explanation of capital flow terms: Refers to inferring capital flow through price changes. When the stock price is rising, the transaction volume generated by active buy orders is the force driving the stock price up, which is defined as capital inflow. When the stock price is falling, the transaction volume generated by active sell orders is the force driving the stock price down, which is defined as capital outflow. The difference between the two on the same day is the net force remaining after offsetting the two forces, driving the stock price higher. Main fund flow, hot money flow, and retail investor flow are calculated based on transaction amounts of individual trades.
Note: Main funds refer to large single transactions, hot money refers to big single transactions, and retail investors refer to small and medium-sized transactions.
The above content is compiled by Securities Star from publicly available information, generated by AI algorithms (Wangxin Algorithm Backup 310104345710301240019), and does not constitute investment advice.